|
ZNF57 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.4514000000091E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.369890E-04 |
| Normal-vs-Stage2 |
5.863900E-03 |
| Normal-vs-Stage3 |
9.88729999999993E-05 |
| Normal-vs-Stage4 |
5.65590000000116E-05 |
| Stage1-vs-Stage2 |
3.613200E-01 |
| Stage1-vs-Stage3 |
5.925000E-01 |
| Stage1-vs-Stage4 |
3.850400E-01 |
| Stage2-vs-Stage3 |
2.267600E-01 |
| Stage2-vs-Stage4 |
1.262350E-01 |
| Stage3-vs-Stage4 |
6.672000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.69009999999781E-05 |
| Normal-vs-AfricanAmerican |
4.075000E-03 |
| Normal-vs-Asian |
5.802900E-03 |
| Caucasian-vs-AfricanAmerican |
6.374400E-01 |
| Caucasian-vs-Asian |
1.622220E-01 |
| AfricanAmerican-vs-Asian |
6.071000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.846400E-04 |
| Normal-vs-Female |
7.75760000000236E-05 |
| Male-vs-Female |
5.993400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.178850E-04 |
| Normal-vs-Age(41-60Yrs) |
1.417520E-04 |
| Normal-vs-Age(61-80Yrs) |
5.382300E-04 |
| Normal-vs-Age(81-100Yrs) |
3.544500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.663200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.655800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.598000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.647200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.258600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.777600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.581620E-01 |
| Classical-VS-Follicular |
2.300400E-01 |
| Classical-VS-Other |
4.572600E-01 |
| Classical-VS-Normal |
2.042900E-04 |
| Tall-VS-Follicular |
6.424400E-02 |
| Tall-VS-Other |
9.875000E-01 |
| Tall-VS-Normal |
7.96290000000255E-05 |
| Follicular-VS-Other |
3.105200E-01 |
| Follicular-VS-Normal |
4.584800E-03 |
| Other-VS-Normal |
4.788000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.601900E-04 |
| Normal-vs-N1 |
3.15439999998279E-06 |
| N0-vs-N1 |
2.793900E-02 |
|
|
